A conversation with Ron Busby, Sr., President and CEO of the U.S. Black Chambers, Inc. on improving vaccine confidence in communities of color
By Stephen J. Ubl | May 5, 2021
The COVID-19 pandemic exposed and often exacerbated the significant systemic health inequities that underserved communities have faced for many years. Black Americans have been particularly...
Read More
Reflecting on Mental Health Awareness Month
By Andrew Powaleny | May 4, 2021
As communities around the world continue to grapple with the impact of COVID-19, the importance of furthering our understanding of the impact on our mental health is undeniable.
Read More
Patient safety is at the heart of COVID-19 vaccine R&D
By Richard Moscicki, M.D. | April 26, 2021
As the world continues to feel the impact of the COVID-19 pandemic, the biopharmaceutical industry is continuing working around the clock to research, develop and manufacture vaccines to prevent...
Read More
Diversifying clinical trials and fighting disease requires equity and trust
By Rebecca Marklund | April 12, 2021
The COVID-19 pandemic has left no person unaffected, but Black Americans have been disproportionately impacted. Black adults are nearly four times more likely to be hospitalized from the virus and...
Read More
ICYMI: WSJ showcases breakthrough science of COVID-19 vaccines and implications for future medicines
By Andrew Powaleny | March 8, 2021
Building on deep scientific knowledge gained from decades of experience with viruses such as MERS, SARS, influenza, HIV and Hepatitis C, biopharmaceutical companies have made unprecedented progress
Read More
Intellectual property is the key to vaccine development, manufacturing and technology sharing
By Megan Van Etten | March 5, 2021
Earlier today, 31 PhRMA board members signed a letter to President Joe Biden applauding the Administration’s accelerating COVID-19 vaccine rollout, but also warning against efforts to undermine...
Read More
How industry collaboration and partnerships are supporting COVID-19 vaccine manufacturing
By Richard Moscicki, M.D. | March 4, 2021
Across the industry, biopharmaceutical companies are working around the clock to meet the demands of COVID-19 vaccine manufacturing. Companies are working to source needed raw materials and other...
Read More
Coming together to fight COVID-19: A conversation with Paul Perreault, CEO and Managing Director of CSL
By Stephen J. Ubl | February 24, 2021
This year, our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections.
Read More
ICYMI: Report provides actionable recommendations to strengthen America’s preparedness and future health crises response
By Jocelyn Ulrich | February 22, 2021
As America’s biopharmaceutical researchers continue working around the clock to fight COVID-19, leaders in the health care ecosystem have come together to provide recommendations to strengthen...
Read More
Fighting variants of COVID-19
By Richard Moscicki, M.D. | February 22, 2021
As the world continues to feel the impact of the COVID-19 pandemic, the biopharmaceutical industry is working around the clock to develop and manufacture safe and effective vaccines. To date, two...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
